Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2016 - Key Vendors are Addex Therapeutics, Bionomics & Eli Lilly and Company - Research and Markets

Research and Markets
Posted on: 18 Nov 16

Research and Markets has announced the addition of the "Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder (PTSD) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • Addex Therapeutics Ltd
  • Amorsa Therapeutics Inc.
  • Azevan Pharmaceuticals, Inc.
  • Bionomics Limited
  • Catalyst Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Humanetics Corporation
  • Intra-Cellular Therapies, Inc.
  • INVENT Pharmaceuticals, Inc.
  • Marinus Pharmaceuticals,

Key Topics Covered:

  1. Introduction
  2. Post-Traumatic Stress Disorder (PTSD) Overview
  3. Therapeutics Development
  4. Pipeline Products for Post-Traumatic Stress Disorder (PTSD) - Overview
  5. Pipeline Products for Post-Traumatic Stress Disorder (PTSD) - Comparative Analysis
  6. Post-Traumatic Stress Disorder (PTSD) - Therapeutics under Development by Companies
  7. Post-Traumatic Stress Disorder (PTSD) - Therapeutics under Investigation by Universities/Institutes
  8. Post-Traumatic Stress Disorder (PTSD) - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Post-Traumatic Stress Disorder (PTSD) - Products under Development by Companies
  13. Post-Traumatic Stress Disorder (PTSD) - Products under Investigation by Universities/Institutes
  14. Post-Traumatic Stress Disorder (PTSD) - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/s3tg8x/posttraumatic

View source version on businesswire.com: http://www.businesswire.com/news/home/20161118005318/en/

Business Wire
www.businesswire.com

Last updated on: 18/11/2016

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.